CZChuisheng Zeng

Chuisheng Zeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chuisheng Zeng has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Feibo Xu

    School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China

    1 shared publication
  • Fengying Liu

    School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China

    1 shared publication
  • Jianzhong Shu

    Department of Encephalopathy, Chongqing Hospital of Traditional Chinese Medicine, 400015 Chongqing, China

    1 shared publication
  • Qianqian Liang

    School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China

    1 shared publication
  • Xiaohong He

    School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China

    1 shared publication
  • Xie Yongfang

    Chongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications, Chongqing 400065, China

    1 shared publication

Latest Publications

  • Open Access

    Evaluating the Mechanisms of Action of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Ischemic Stroke

    by Jianzhong Shu, Qianqian Liang, Xiaohong He, Chuisheng Zeng, Yuhan Huang, Fengying Liu, Feibo Xu, Xuetong Yong, Yongfang Xie

    The utilization of cell-free therapies derived from extracellular vesicles (EVs) has garnered mounting interest as a promising approach to address the myriad challenges associated with ischemic stroke. These Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) possess considerable therapeutic potential due to their inherent properties, including low immunogenicity, efficient cargo transportation, and the ability to cross the blood-brain barrier. This review examines the mechanisms underlying mesenchymal stem cell-derived EVs in the treatment of ischemic stroke. Future research should aim to identify optimal strategies for EV-based interventions, including combination therapy and preconditioning strategies.